Direxion Daily Healthcare Bull 3x Shares ETF (CURE) - NYSEARCA
  • Thu, Apr. 14, 3:58 AM
    | Thu, Apr. 14, 3:58 AM | 7 Comments
  • Tue, Mar. 15, 4:07 AM
    • The average price of branded prescription drugs in the U.S. has doubled in the past five years, a finding that threatens to fuel the political backlash against high prices.
    • Express Scripts (NASDAQ:ESRX), the country's largest pharmacy group, said the average wholesale price of branded medicines, which are protected by patents, rose 16% last year and was up a total of 98% since 2011.
    • High drug costs have become a persistent theme in the current U.S. election campaigns, with both the Democratic and Republican frontrunners, Hillary Clinton and Donald Trump, pledging to crack down on elevated prices.
    • ETFs: XLV, IYH, VHT, PJP, CURE, HQH, XPH, RXL, FXH, IHE, FHLC, PPH, RYH, THQ, RXD
    | Tue, Mar. 15, 4:07 AM | 20 Comments
  • Oct. 26, 2015, 11:39 AM
    • It's been a "remarkable turn" in relative performance, says Deutsche Bank's David Bianco, noting health care was about 1K basis points ahead of the S&P 500 as recently as mid-August, but both are now about flat and neck-and-neck year-to-date.
      "We find this reversal unwarranted and think health care could surge into year-end," says Bianco, and if the move doesn't come in 2015, it'll surely happen next year. As for valuation, health care is selling for 14.7x 2016E EPS vs. the S&P 500 at 16x - this even as health care's expected 6% sales growth should easily trump that of nominal GDP and the S&P 500. Biano sees 6-9% EPS growth, also better than the S&P.
    • Focus on the big picture, says Bianco: "We believe growth in health care products will stay strong owing to an aging population and increasing efforts to treat conditions with drugs and maximize the productivity of scarce healthcare labor with as many tools and conveniences as conceivable." He likes S&P 500 biotech, pharma, devices, equipment, supplies, tech, and tools, but is cautious on managed care and other healthcare services and facilities.
    • ETFs: IBB, IYH, XLV, XBI, VHT, PJP, BBH, FBT, HQH, CURE, XPH, HQL, PBE, FXH, RXL, IHE, FHLC, SBIO, IHF, PPH, IHI, XHS, RYH, BBC, THQ, PSCH, BBP, XHE, RXD, CNCR, LABD, LABU, UBIO, ZBIO
    | Oct. 26, 2015, 11:39 AM | 15 Comments
  • Oct. 13, 2015, 3:49 PM
    • Getting out in front of what should be more bashing of their business models at the Democratic debate tonight, the healthcare names (XLV -1.3%) have about doubled the decline in the S&P 500. Within healthcare, it's the biotechs (IBB -3.1%) and pharmaceuticals (XPH -3.2%) leading the way south.
    • Celgene (CELG -3.3%), Biogen (BIIB -3.6%), Amgen (AMGN -3.5%), Allergan (AGN -4.1%), Mylan (MYL -3.6%)
    • The biotech heavy Russell 2000 (IWM -1.4%) is feeling the pain as well.
    • ETFs: IBB, IYH, XLV, XBI, VHT, PJP, BBH, FBT, HQH, CURE, XPH, HQL, PBE, FXH, RXL, IHE, FHLC, SBIO, PPH, RYH, BBC, THQ, BBP, RXD, LABU, LABD, UBIO, ZBIO
    | Oct. 13, 2015, 3:49 PM | 27 Comments
  • Sep. 25, 2015, 3:07 PM
    | Sep. 25, 2015, 3:07 PM | 134 Comments
  • Apr. 21, 2015, 11:37 AM
    • In the case of eight of the leveraged funds, the share prices have gotten too cheap and reverse splits are necessary: BRZU, YANG, GASL, MIDZ, LBJ, RUSS, SOXS, TECS. The first three ETFs are slated for 1:10 reverse splits, and the last five 1:4.
    • For the other 11 leveraged funds, the share prices have gotten too pricey: MIDU, INDL, CURE, RETL, SOXL, FAS, TECL, SPUU, MDLL, SMLL, SYTL. All are 4:1 splits, except SYTL which is 2:1.
    • All will begin trading on a post-split basis on May 20.
    | Apr. 21, 2015, 11:37 AM | 3 Comments
  • Mar. 5, 2015, 2:08 PM
    | Mar. 5, 2015, 2:08 PM | 4 Comments
  • Jun. 5, 2014, 8:00 AM
    • A Saudi Arabian man who died of Middle East respiratory syndrome (MERS) probably caught the disease from one of his sick dromedary camels that he treated for a nasal discharge a month earlier. Samples taken from the man and camel found a genetically identical virus. This is the first conclusive evidence that camels may be the intermediate hosts of the bug. The exact reservoir the maintains the virus in its ecologic niche has yet to be identified, however.
    • The Saudi man fell ill about seven days after treating the camel with a topical medicine. He and three friends visited the camels daily but his friends, who had no direct contact with the animal, remained free of the virus.
    • Healthcare ETFs: IYH, XLV, VHT, CURE, FXH, RXL, FHLC, RYH, RXD
    | Jun. 5, 2014, 8:00 AM | 2 Comments
  • May 9, 2014, 12:09 PM
    • At last night's GeekWire Awards ceremony in Seattle, Leafly won App of the Year. The mobile app, described by some as the "Yelp of cannabis" helps pot consumers stay informed about cannabis strains, products and the best places to purchase them. It also connects patients to doctors who can assist them through the medical authorization process. It contains over 100K user-generated reviews of more than 800 cannabis strains as well as thousands of dispensaries and doctor locations around the world. GeekWire praised its functionality and clean professional appearance.
    • Leafly founder Cy Scott says, "Our team is truly honored to receive this award. When we released the app, our goal was to offer a simple way for medical and recreational cannabis consumers to get robust information at their fingertips. This award is a win for all who support the cannabis movement."
    • (MDBX) (MJMJ) (REFG) (SKTO) (ERBB) (CBCA) (AVTC) (AEGY)
    • ETFs: IYH, XLV, VHT, CURE, FXH, RXL, FHLC, PSCH, RYH, PTH, RXD
    | May 9, 2014, 12:09 PM | 5 Comments
  • May 8, 2014, 7:35 AM
    • China intends to end price limits on low-cost drugs after the controls caused quality problems and shortages.
    • China's economic planning body, the National Development & Reform Commission, will lift price caps on 280 drugs provided by Western companies and 250 Chinese patent medicines.
    • Sanofi (SNY) and Pfizer (PFE) said it's too early to ascertain the impact of the new policy. Other companies that could be affected include GlaxoSmithKline (GSK).
    • ETFs: IYH, IBB, XLV, XBI, VHT, BIB, PJP, BBH, FBT, PBE, XPH, CURE, FXH, IHE, RXL, IRY, IXJ, PPH, BIS, FHLC, PSCH, RYH, PTH, DRGS, RXD
    | May 8, 2014, 7:35 AM
  • Apr. 25, 2014, 2:49 PM
    • Much of the high tech equipment hospitals use can be easily hacked and could pose a significant danger to patients according to the head of information security at Essentia Health.
    • Imaging equipment, insulin pumps, defibrillators and refrigerators that store blood and drugs are examples of networked gear that have remote access control features.
    • The devices' software is plagued by common security holes like weak passwords, lack of authentication to access, easy-to-determine default and hard-coded passwords and embedded web servers and administrative interfaces that make it easy to identify and manipulate devices once found on the network.
    • Hospital are apparently just waking up to the potential risks.
    • Last spring, the FDA and DHS issued a notice to the health care industry about problems with hard-coded passwords after researchers found issues in ~300 devices.
    • ETFs: IYH, IBB, XLV, XBI, VHT, BIB, PJP, BBH, FBT, PBE, XPH, CURE, FXH, IHE, RXL, IRY, IXJ, PPH, IHI, BIS, IHF, FHLC, XHS, PSCH, RYH, XHE, PTH, DRGS, RXD
    | Apr. 25, 2014, 2:49 PM
  • Apr. 22, 2014, 12:14 PM
    | Apr. 22, 2014, 12:14 PM
  • Apr. 22, 2014, 11:33 AM
    • The FDA proposes an "Expedited Access PMA" (EAP) process for medical devices that treat or diagnose patients with serious conditions whose medical needs are unmet by current technology. The program features earlier and more interactive participation by agency staff to collaboratively develop a plan for the collection of the scientific and clinical data to support approval. The EAP aims to reduce certain devices' development times in addition to the expected shortened premarket review.
    • Eligible devices must fit the following profile: 1) be intended to treat or diagnose a life-threatening or irreversibly-debilitating disease or condition and 2) represent one of the following: no approved alternative treatment/diagnostic exists or it represents a breakthrough technology that provides a clinically meaningful advantage over existing technology or offers a significant clinically meaningful advantage over currently-available alternatives or the device's availability is in the patient's best interest.
    • The proposed EAP builds on the Expedited Access Program for pharmaceuticals that the FDA launched in 2011.
    • Draft guidance
    • Healthcare ETFs: IYH, IBB, XLV, XBI, VHT, BIB, PJP, BBH, FBT, PBE, XPH, CURE, FXH, IHE, RXL, IRY, IXJ, PPH, IHI, BIS, IHF, FHLC, XHS, PSCH, RYH, XHE, PTH, DRGS, RXD
    | Apr. 22, 2014, 11:33 AM
  • Apr. 17, 2014, 2:15 PM
    • Texas researchers predict that one in twenty or ~12M people in outpatient settings in the U.S. are misdiagnosed by doctors each year. About half could potentially harm patients.
    • They analyzed 3,000 patient records and found a misdiagnosis rate of 5%. Extrapolating the rate to the 80% of U.S. adults who receive outpatient medical care yields 12M people.
    • Faulty medical records and other potential flaws in the data could mean the real misdiagnosis rate is higher.
    • The study's lead author, Dr. Hardeep Singh of Baylor College of Medicine, hopes his team's findings give quality-of-care stakeholders a clearer sense of the problem.
    • ETFs: IYH, XLV, VHT, CURE, FXH, RXL, IRY, IXJ, IHF, FHLC, XHS, PSCH, RYH, PTH, RXD
    | Apr. 17, 2014, 2:15 PM
  • Apr. 17, 2014, 1:49 PM
    | Apr. 17, 2014, 1:49 PM | 1 Comment
  • Apr. 17, 2014, 1:30 PM
    • Scientists create patient-specific cell lines from the skin cells of two adult men in a procedure called somatic cell nuclear transfer demonstrating that the technique can work for people of all ages. The embryonic cells are genetically identical to the donor and have profound therapeutic potential.
    • The cloning procedure is difficult, however. Only one in thirty-nine attempts was successful.
    • In therapeutic cloning, a jolt of electricity fuses a grown cell (e.g. skin cell) with an ovum whose DNA has been removed. After ~5 days of dividing and multiplying it develops into a hollow sphere-shaped embryo. The interior cells are pluripotent stem cells which can develop into many different kinds of cells. The goal is to coax them to develop into specialized cells for therapeutic purposes.
    • Complicating the ability to create patient-specific cell lines for millions of people are women's reticence over donating eggs, a sometimes painful process. Widespread donations may not be ultimately necessary since many people have genetically similar immune systems so 100 human embryonic stem cell lines would match over 50% of the U.S. population according to the co-author of the study, Dr. Robert Lanza.
    • Healthcare ETFs: IYH, IBB, XLV, XBI, VHT, BIB, PJP, BBH, FBT, PBE, XPH, CURE, FXH, IHE, RXL, IRY, IXJ, PPH, IHI, BIS, IHF, FHLC, XHS, PSCH, RYH, PTH, XHE, DRGS, RXD
    | Apr. 17, 2014, 1:30 PM
CURE Description
The Daily Healthcare Bull 3x Shares seeks daily investment results, before fees and expenses, of 300% of the price performance of the Healthcare Select Sector Index. There is no guarantee the fund will meet its stated investment objective.
See more details on sponsor's website
Country: United States
ETF Hub
Find the right ETFs for your portfolio: Visit Seeking Alpha's ETF Hub